Skip to main content
Clinical Trials/IRCT20170702034844N8
IRCT20170702034844N8
Not yet recruiting
未知

Guided smartphone-based treatment for patients in opioid maintenance treatment in Iran - transdiagnostic treatment for substance use and common mental disorders

Swiss Research Institute of Public Health and Addiction (ISGF)0 sites400 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Swiss Research Institute of Public Health and Addiction (ISGF)
Enrollment
400
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Swiss Research Institute of Public Health and Addiction (ISGF)

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Minimal age of 18 years
  • Stabilization on methadone or buprenorphine dosage for at least 3 weeks
  • Ownership of a smartphone and a valid email address
  • Good command of Persian
  • Appropriate geographical access to the study site in Tehran

Exclusion Criteria

  • Concurrent benzodiazepine, (meth\-)amphetamine, or cocaine dependence
  • Current pharmacologically\-treated severe psychiatric disease, like schizophrenia or bipolar type I disorder, or significant current suicidal or homicidal thoughts

Outcomes

Primary Outcomes

Not specified

Similar Trials